EBOS GROUP LIMITED — Director's Dealing 2024

Aug 29, 2024

==> picture [93 x 27] intentionally omitted <==

Initial Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(1) and 298(1), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:			30-Aug-24
Date on which issuer listed or appointment made:			1-Nov-21
Director or senior manager giving disclosure
Full name:		Julie Dillon
Name of listed issuer:		EBOS GroupLimited
Name of related bodycorporate(if applicable):		N/A
Position held in listed issuer:		CEO Animal Care

Summary of relevant interest (excluding specified derivatives)

Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product:		Ordinary shares
Number held in class:		8,082
Nature of relevant interest:		Registered holder (issued pursuant toperformance rightsplan)
Current registered holder:		Julie Dillon

Summary of specified derivatives relevant interest (if applicable)

Type of derivative:		N/A
Class of underlying financial products:		N/A
Details of derivative
The notional value of the derivative (if any) or the notional amount of underlying products (if any):		N/A
A statement as to whether the derivative is cash settled or physically settled:		N/A
Maturity date of the derivative (if any):		N/A
Expiry date of the derivative (if any):		N/A
The price specified in the terms of the derivative(if any):		N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the		N/A
underlying financial products:
For that derivative,-
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:		N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:		30-Aug-24
Name and title of authorised person:		Janelle Cain, General Counsel EBOS Group Limited

==> picture [98 x 36] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		30-Aug-24
Date of last disclosure:		1-Sep-23
Director or senior managergiving disclosure
Full name(s):		Brett Barons
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		CEO,Symbion
Summary of acquisition or disposal of relevant interest(excluding specified derivatives) Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest-
Class ofaffected quotedfinancialproducts:		Ordinaryshares
Nature of the affected relevant interest(s):		Issue of shares pursuant to performance rightsplan
For that relevant interest-
Number held in class before acquisition or disposal:		45,777 ordinaryshares
Number held in class after acquisition or disposal:		68,069 ordinaryshares
Current registered holder(s):		N/A
Registered holder(s) once transfers are registered:		Brett Barons

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) Type of affected derivative: Class of underlying financial products: Details of affected derivative- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative(if any): The price specified in the terms of the derivative (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

Details of transactionsgiving rise to acquisition or disposal
Total number of transactions to which notice relates:		1
		30-Aug-24
		Issue of shares pursuant to performance rightsplan
		N/A
		Nil
		22,292 ordinaryshares

Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):

No N/A N/A

Summary of other relevant interests after acquisition or disposal: Class of quoted financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative: Details of derivative,-

Ordinary shares 1. Registered holder - 2016 long term incentive plan 2. Registered holder - 2017 long term incentive plan 1. 55,000 ordinary shares 2. 55,000 ordinary shares Brett Barons

The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

==> picture [55 x 16] intentionally omitted <==

30-Aug-24 Janelle Cain, General Counsel, EBOS Group Limited

==> picture [98 x 36] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		30-Aug-24
Date of last disclosure:		6-Sep-22
Director or senior managergiving disclosure
Full name(s):		John Cullity
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Chief Executive Officer
Summary of acquisition or disposal of relevant interest(excluding specified derivatives) Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest-
Class ofaffected quotedfinancialproducts:		Ordinaryshares
Nature of the affected relevant interest(s):		Issue of shares pursuant to performance rightsplan
For that relevant interest-
Number held in class before acquisition or disposal:		24,186 ordinaryshares
Number held in class after acquisition or disposal:		71,248 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		John Cullity
		le)
Type of affected derivative:
Class of underlyingfinancial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products(if any):
A statement as to whether the derivative is cash settled or physicallysettled:
Maturitydate of the derivative(if any):
Expirydate of the derivative(if any):
Theprice specified in the terms of the derivative(if any):
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financialproducts:
_For that derivative,- _
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Details of transactionsgiving rise to acquisition or disposal
Total number of transactions to which notice relates:		1
		30-Aug-24
		Issue of shares pursuant to performance rightsplan
		N/A
		Nil
		47,062 ordinaryshares

Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):

No N/A N/A Ordinary shares 1. Registered holder - 2016 long term incentive plan 2. Registered holder - 2017 long term incentive plan 3. Elizabeth Mary Coutts & John Matthew Cullity as trustees for the EBOS Staff Share Plan 1. 95,000 ordinary shares 2. 110,000 ordinary shares 3. 71,592 ordinary shares 1&2 John Cullity 3. Elizabeth Mary Coutts & John Matthew Cullity as trustees for the EBOS Staff Share Plan

Summary of other relevant interests after acquisition or disposal:

		Ordinaryshares
		1. Registered holder - 2016 long term incentive plan 2. Registered holder - 2017 long term incentive plan 3. Elizabeth Mary Coutts & John Matthew Cullity as trustees for the EBOS Staff Share Plan
		1. 95,000 ordinary shares 2. 110,000 ordinary shares 3. 71,592 ordinary shares
		1&2 John Cullity 3. Elizabeth Mary Coutts & John Matthew Cullity as trustees for the EBOS Staff Share Plan
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financialproducts:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

==> picture [45 x 13] intentionally omitted <==

30-Aug-24 Janelle Cain, General Counsel, EBOS Group Limited

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:			30-Aug-24
Date of last disclosure:			28-Mar-24
Director or senior managergiving disclosure
Full name(s):		Leonard Hansen
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Chief Financial Officer

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		30-Aug-24
Date of last disclosure:		28-Mar-24
Director or senior managergiving disclosure
Full name(s):		Leonard Hansen
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Chief Financial Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class of affected quoted financial products: Ordinaryshares Nature of the affected relevant interest(s): Issue of shares pursuant to performance rightsplan For that relevant interest-
Class of affected quoted financial products:		Ordinaryshares
Nature of the affected relevant interest(s):		Issue of shares pursuant to performance rightsplan
For that relevant interest-
Number held in class before acquisition or disposal:		14,624
Number held in class after acquisition or disposal:		23,293
Current registered holder(s):		N/A
Registered holder(s) once transfers are registered:		Leonard Hansen

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) Type of affected derivative: Class of underlying financial products: Details of affected derivative- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative(if any): The price specified in the terms of the derivative (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:		1
		30-Aug-24
		Issue of shares pursuant to performance rightsplan
		N/A

The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):

Nil 8,669 ordinary shares No N/A N/A

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s):gistered holder(s):istered holder(s):(s):s):)::

Number held in class: Current registered holder(s):gistered holder(s):istered holder(s):(s):s):):: For a derivative relevant interest,- Type of derivative: Details of derivative,- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

==> picture [75 x 17] intentionally omitted <==

30-Aug-24 Janelle Cain, General Counsel, EBOS Group Limited